307
Views
14
CrossRef citations to date
0
Altmetric
Research Article

TRO19622 promotes myelin repair in a rat model of demyelination

, , , , &
Pages 810-822 | Received 03 Apr 2013, Accepted 08 May 2013, Published online: 05 Jun 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Rujapope Sutiwisesak, Terry C. Burns, Moses Rodriguez & Arthur E. Warrington. (2021) Remyelination therapies for multiple sclerosis: optimizing translation from animal models into clinical trials. Expert Opinion on Investigational Drugs 30:8, pages 857-876.
Read now
Pablo Villoslada & Lawrence Steinman. (2020) New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis. Expert Opinion on Investigational Drugs 29:5, pages 443-459.
Read now

Articles from other publishers (11)

Heena Khan, Nikhil Garg, Thakur Gurjeet Singh, Amarjot Kaur & Komal Thapa. (2022) Calpain Inhibitors as Potential Therapeutic Modulators in Neurodegenerative Diseases. Neurochemical Research 47:5, pages 1125-1149.
Crossref
Gunter P. Eckert, Schamim H. Eckert, Janett Eckmann, Stephanie Hagl, Walter E. Muller & Kristina Friedland. (2020) Olesoxime improves cerebral mitochondrial dysfunction and enhances Aβ levels in preclinical models of Alzheimer's disease. Experimental Neurology 329, pages 113286.
Crossref
Li Li, Rongwen Li, Alex Zacharek, Fengjie Wang, Julie Landschoot-Ward, Michael Chopp, Jieli Chen & Xu Cui. (2020) ABCA1/ApoE/HDL Signaling Pathway Facilitates Myelination and Oligodendrogenesis after Stroke. International Journal of Molecular Sciences 21:12, pages 4369.
Crossref
Michael Enders, Thorsten Heider, Andreas Ludwig & Stefanie Kuerten. (2020) Strategies for Neuroprotection in Multiple Sclerosis and the Role of Calcium. International Journal of Molecular Sciences 21:5, pages 1663.
Crossref
Jonasz Jeremiasz Weber, Laura Emily Clemensson, Helgi Birgir Schiöth & Huu Phuc Nguyen. (2019) Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidate. Biochemical Pharmacology 168, pages 305-318.
Crossref
Wendy Oakden, Nicholas A. Bock, Alia Al-Ebraheem, Michael J. Farquharson & Greg J. Stanisz. (2017) Early regional cuprizone-induced demyelination in a rat model revealed with MRI. NMR in Biomedicine 30:9, pages e3743.
Crossref
Daniela Vieira BuchaimJesus Carlos AndreoRui Seabra Ferreira JuniorBenedito BarravieraAntonio de Castro RodriguesMariana de Cássia MacedoGeraldo Marco Rosa JuniorAndre Luis ShinoharaIris Jasmin Santos GermanKarina Torres PominiRogerio Leone Buchaim. (2017) Efficacy of Laser Photobiomodulation on Morphological and Functional Repair of the Facial Nerve. Photomedicine and Laser Surgery 35:8, pages 442-449.
Crossref
Daniela Vieira Buchaim, Antonio de Castro Rodrigues, Rogerio Leone Buchaim, Benedito Barraviera, Rui Seabra Ferreira Junior, Geraldo Marco Rosa Junior, Cleuber Rodrigo de Souza Bueno, Domingos Donizeti Roque, Daniel Ventura Dias, Leticia Rossi Dare & Jesus Carlos Andreo. (2016) The new heterologous fibrin sealant in combination with low-level laser therapy (LLLT) in the repair of the buccal branch of the facial nerve. Lasers in Medical Science 31:5, pages 965-972.
Crossref
Jelle Praet, Caroline Guglielmetti, Zwi Berneman, Annemie Van der Linden & Peter Ponsaerts. (2014) Cellular and molecular neuropathology of the cuprizone mouse model: Clinical relevance for multiple sclerosis. Neuroscience & Biobehavioral Reviews 47, pages 485-505.
Crossref
Yinghua Xuan, Gen Yan, Hui Peng, Renhua Wu & Haiyun Xu. (2014) Concurrent changes in 1H MRS metabolites and antioxidant enzymes in the brain of C57BL/6 mouse short-termly exposed to cuprizone: Possible implications for schizophrenia. Neurochemistry International 69, pages 20-27.
Crossref
Nabeela Nathoo, V Wee Yong & Jeff F Dunn. (2013) Using magnetic resonance imaging in animal models to guide drug development in multiple sclerosis. Multiple Sclerosis Journal 20:1, pages 3-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.